Skip to main content
SpringerLink
Log in

Guillian Barré Syndrome — Recent advances

  • Basic & Behavioural Sciences
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Guillian Barré Syndrome (GBS) is an acquired disease of the peripheral nerves that is characterized clinically by rapidly progressing paralysis, areflexia, and albumino-cytological dissociation. It affects both genders, involves people of all ages, is reported worldwide, and in the post-polio era, it is the most common cause of an acute generalized paralysis. The clinical features are distinct and a history and an examination generally lead to a high suspicion of the diagnosis that can then be confirmed by supportive laboratory tests and electrodiagnostic studies. This review discusses the recent advances in understanding of the different variants of GBS such as acute inflammatory demyelinating polyneuropathy (AIDP), acute motor axonal neuropathy (AMAN), acute motor sensory axonal neuropathy (AMSAN), and the Fisher syndrome. The clinical, electrodiagnostic criteria, immunopathogenesis, and management of GBS and its variants are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Landry O. Note sur la paralysie ascendante aigue.Gazette Hebdomadaire 1859; 6: 472.

    Google Scholar 

  2. Guillain G, Barré JA, Strohl A. Sur un syndrome de radiculo-nevrite avec hyperalbuminose du liquide cephalo-rachidien sans reaction cellulaire. Remarques sur les caracteres cliniques et graphiques des reflexes tendineux.Bulletins et memories de la Societe Medicale des hopitaux de Paris 1916; 40: 1462.

    Google Scholar 

  3. Haymaker W, Kernohan JW. The Landry-Guillain-Barré Syndrome: clinicopathologic report of fifty fatal cases and critique of the literature.Medicine 1949; 28: 59.

    PubMed  CAS  Google Scholar 

  4. Ropper AH, Wijdicks EFM, Truax BT. Epidemiology. In: Guillain-Barré Syndrome, F Plum, ed. Contemporary Neurology Series. Philadelphia: FA Davis 1991; pp. 22–30.

    Google Scholar 

  5. Alter M. The epidemiology of Guillain-Barré syndrome.Ann Neurol 1990; 27 (Suppl): S7.

    Article  Google Scholar 

  6. World Health Organization.Weekly Epidemiol Rec No 1979; 11: 82–83.

    Google Scholar 

  7. McKhann GM, Cornblath DR, Griffin JWet al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China.Ann Neurol 1993; 33: 333.

    Article  PubMed  CAS  Google Scholar 

  8. Ramos-Alvarez M, Bessudo L, Sabin AB. Paralytic syndromes associated with non-inflammatory cytoplasmic or nuclear neuronopathy. Acute paralytic disease in Mexican children neuropathologically distinct from Landry-Guillain-Barré Syndrome.JAMA 1969; 207: 1481.

    Article  PubMed  CAS  Google Scholar 

  9. Hodges GR, Perkins RL. Landry-Guillain-Barré syndrome associated with Mycoplasma pneumoniae infection.JAMA 1969; 210: 2088.

    Article  PubMed  CAS  Google Scholar 

  10. Bernard E, Carles M, Laffont Cet al. Guillain-Barré Syndrome associated with acute Q fever.Eur J Clin Microbiol Infect Dis 1994; 13: 658.

    Article  PubMed  CAS  Google Scholar 

  11. Boucharlat J, Groslambert R, Chateau R. Polyradiculoneuritis as a symptom of varicella.J Med Lyon 1968; 49: 1443.

    PubMed  CAS  Google Scholar 

  12. Amundson DE, Goodman JC. Hodgkin’s disease in association with Guillain-Barré-Strohl Syndrome: case report.Milit Med 1983; 148: 512.

    CAS  Google Scholar 

  13. Arnason BG, Ashbury AK. Idiopathic polyneuritis after surgery.Arch Neurol 1968; 18: 500.

    PubMed  CAS  Google Scholar 

  14. Ono S, Chida K, Takasu T. Guillain-Barré Syndrome following fulminant viral hepatitis-A.Intern Med 1994; 33: 799.

    PubMed  CAS  Google Scholar 

  15. Cornblath DR, McArthur JC, Kennedy PGEet al. Inflammatory demyelinating perpheral neuropathies associated with human T-cell lymphotropic virus type III infection.Ann Neurol 1987; 21: 32.

    Article  PubMed  CAS  Google Scholar 

  16. Waksman BH, Adams RD. Allergic neuritis: An experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants.J Exp Med 1955; 102: 213.

    Article  PubMed  CAS  Google Scholar 

  17. Smith ME, Forno LS, Hofmann WW. Experimental allergic neuritis in the Lewis rat.J Neuropathol Exp Neurol 1979; 38: 377.

    PubMed  CAS  Google Scholar 

  18. Brostoff SW, Burnett P, Lampert PWet al. Isolation and characterization of a protein from sciatic nerve myelin responsible for experimental allergic neuritis.Nature 1972; 235: 210.

    CAS  Google Scholar 

  19. Rostami AM, Brown MJ, Lisak RPet al. The role of myelin P2 protein in the production of experimental allergic neuritis.Ann Neurol 1984; 16: 680.

    Article  PubMed  CAS  Google Scholar 

  20. Rostami AM, Gregorian SK. Peptide 53–78 of myelin P2 protein is a T-cell epitope for the induction of experimental allergic neuritis.Cell Immunol 1991; 132: 433.

    Article  PubMed  CAS  Google Scholar 

  21. Rostami AM, Burns JB, Brown MJet al. Transfer of experimental allergic neuritis with P2-reactive T-cells.Ann Neurol 1983; 14: 108.

    Google Scholar 

  22. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis.Medicine 1969; 48: 173–215.

    Article  PubMed  CAS  Google Scholar 

  23. Rosen JL, Brown MJ, Hickey WFet al. Early myelin lesions in experimental allergic neuritis.Muscle Nerve 1990; 13: 629.

    Article  PubMed  CAS  Google Scholar 

  24. Hartung H-P, Hughes RAC, Taylor WAet al. T-cell activation in Guillain-Barré Syndrome and in MS: elevated serum levels of soluble IL-2 receptors.Neurology 1990; 40: 215.

    PubMed  CAS  Google Scholar 

  25. Prineas JW. Pathology of the Guillain-Barré Syndrome.Ann Neurol 1981; 9 (Suppl): S6.

    Article  PubMed  Google Scholar 

  26. Brechenmacher C, Vital C, Deminiere C,et al. Guillain-Barré Syndrome: an ultrastructural study of peripheral nerve in 65 cases.Clin Neuropathol 1987; 6: 19.

    PubMed  CAS  Google Scholar 

  27. Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P, Mishu B, Cornblath DR, Macko C, McKhann GM, Asbury AK. Pathology of the motor-sensory axonal Guillain-Barré Syndrome.Ann Neurol 1996 Jan; 39(1): 17–28.

    Article  PubMed  CAS  Google Scholar 

  28. Griffin JW, Macko C, Ho Tet al. Vesicular demyelination in acute inflammatory demyelinating polyneuropathy (AIDP): implications for pathogenesis.Neurology 1995; 45 (Suppl): A415.

    Google Scholar 

  29. Feasby TE, Gilbert JJ, Brown WF,et al. An acute axonal form of Guillain-Barré polyneuropathy.Brain 1986; 109: 1115.

    Article  PubMed  Google Scholar 

  30. Feasby TE. Axonal Guillain-Barré Syndrome.Muscle Nerve 1994; 17: 678.

    Article  PubMed  CAS  Google Scholar 

  31. Griffin JW, Li CY, Ho TWet al. Guillain-Barré Syndrome in northern China—the spectrum of neuropathologic changes in clinically defined cases.Brain 1995; 118: 577.

    Article  PubMed  Google Scholar 

  32. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM. Guillain-Barré Syndrome in northern China. Relationship toCampylobacter jejuni infection and anti-glycolipid antibodies.Brain 1995; 118 (3): 597–605.

    Article  PubMed  Google Scholar 

  33. Quarles RH, Ilyas AA, Willison HJ. Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system.Chem Phys Lipids 1986; 42: 235.

    Article  PubMed  CAS  Google Scholar 

  34. Sheikh KA, Nachamkin I, Ho TW, Willison HJ, Veitch J, Ung H, Nicholson M, Li CY, Wu HS, Shen BQ, Cornblath DR, Asbury AK, McKhann GM, Griffin JW. Campylobacter jejuni lipopolysacharides in Guillain-Barré Syndrome: molecular mimicry and host susceptibility.Neurology 1998; 51 (2): 371–378.

    PubMed  CAS  Google Scholar 

  35. Hafer-Macko C, Hsieh ST, Li CY, Ho TW, Sheikh K, Cornblath DR, McKhann GM, Asbury AK, Griffin JW. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma.Ann Neurol 1996; 40 (4): 635–644.

    Article  PubMed  CAS  Google Scholar 

  36. Van der Meche FG, Meulstee J, Kleyweg RP. Axonal damage in Guillain-Barré Syndrome.Muscle Nerve 1991; 14 (10): 997–1002.

    Article  PubMed  Google Scholar 

  37. Griffin JW, Li CY, Macko C, Ho TW, Hsieh ST, Xue P, Wang FA, Cornblath DR, McKhann GM, Asbury AK. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré Syndrome.J Neurocytol 1996; 25 (1): 33–51.

    Article  PubMed  CAS  Google Scholar 

  38. Ho TW, Li CY, Cornblath DR, Gao CY, Asbury AK, Griffin JW, McKhann GM. Patterns of recovery in the Guillain-Barré Syndromes.Neurology 1997; 48 (3): 695–700.

    PubMed  CAS  Google Scholar 

  39. Kaldor J, Speed BR. Guillain-Barré Syndrome andCampylobacter jejuni: A serologic study.BMJ 1984; 288: 1867.

    PubMed  CAS  Google Scholar 

  40. Ho TW, Willison HJ, Nachamkin I, Li CY, Veitch J, Ung H, Wang GR, Liu RC, Cornblath DR, Asbury AK, Griffin JW, McKhann GM. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré Syndrome.Ann Neurol 1999; 45 (2): 168–173.

    Article  PubMed  CAS  Google Scholar 

  41. Vriesendorp FJ, Mishu B, Blaser MJet al. Serum antibodies to GM1, GD1b, peripheral nerve myelin, andCampylobacter jejuni in patients with Guillain-Barré Syndrome and controls: correlation and prognosis.Ann Neurol 1993; 34: 130.

    Article  PubMed  CAS  Google Scholar 

  42. Evans OB and Vedanarayanan V. Guillian-Barré Syndrome.Pediatrics in Review 1997; 18: 10–16.

    Article  PubMed  CAS  Google Scholar 

  43. Thieffrey S, Arthuis M, Monsaller F and Sorrell-Dejerine J. La Maladiedr Guillian Barré chez enfant.Journee de reamination neurorespetoire de L’ Hospital Claude Bernard, 1961; 95: 61–73.

    Google Scholar 

  44. Ropper AH, Wijdicks EFM, Truax BT. Guillian Barré Syndrome in children. In: Guillian Barré Syndrome, F. Plum, ed.Contemporary Neurology Series. FA Davis, Philadelphia. 1991; pp. 124–156.

    Google Scholar 

  45. Chiba A, Kusunoki S, Obata Het al. Serum anti-GQ1bIgG antibody is associated with ophtalmoplegia in Miller-Fisher Syndrome and Guillain-Barré Syn-drome: clinical and immunohistochemical studies.Neurology 1993; 43: 1911.

    PubMed  CAS  Google Scholar 

  46. Willison HJ, Veitch J, Patterson Get al. Miller-Fisher Syndrome is associated with serum antibodies to GQ1b ganglioside.J Neurol Neurosurg Psychiat 1993; 56: 204.

    PubMed  CAS  Google Scholar 

  47. Yuki N, Sata S, Tsuji Set al. Frequent presence of anti-GQ1b antibody in Fisher Syndrome.Neurology 1993; 43: 414.

    PubMed  CAS  Google Scholar 

  48. Ropper AH, Wijdicks EFM, Shahani BT. Electrodiagnostic changes in early Guillain-Barré Syndrome. A prospective study in 113 patients.Arch Neurol 1990; 47: 881.

    PubMed  CAS  Google Scholar 

  49. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré Syndrome.Ann Neurol 1990; 27 (suppl): S21-S24.

    Article  PubMed  Google Scholar 

  50. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy.Muscle Nerve 1985; 8: 528.

    Article  PubMed  CAS  Google Scholar 

  51. Brown WF, Feasby TE. Conduction block and denervation in Guillain-Barré polyneuropathy.Brain 1984; 107: 219.

    Article  PubMed  Google Scholar 

  52. Cornblath DR. Electrophysiology in Guillain-Barré Syndrome.Ann Neurol 1991; 27 (Suppl): S17.

    Article  Google Scholar 

  53. Alam TA, Chaudhry V, Cornblath DR. Electrophysiological studies in the Guillain-Barré Syndrome: distinguishing subtypes by published criteria.Muscle Nerve 1998; 21 (10): 1275–1279.

    Article  PubMed  CAS  Google Scholar 

  54. Cros D, Triggs WJ. There are no neurophysiologic features characteristic of “axonal” Guillain-Barré Syndrome.Muscle Nerve 1994; 17 (6): 675–677.

    Article  PubMed  CAS  Google Scholar 

  55. Wu HS, Liu TC, Lu ZL, Zou LP, Zhang WC, Zhaori G, Zhang J. A prospective clinical and electrophysiologic survey of acute flaccid paralysis in Chinese children.Neurology 1997; 49 (6): 1723–1725.

    PubMed  CAS  Google Scholar 

  56. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy.Muscle Nerve 1985; 8: 528–539.

    Article  PubMed  CAS  Google Scholar 

  57. Albers JW, Kelly JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features.Muscle Nerve 1989; 12: 435–451.

    Article  PubMed  CAS  Google Scholar 

  58. Asbury AK, Arnason BG, Karp HR, mcFarlin DE. Criteria for the diagnosis of Guillain-Barré Syndrome.Ann Neurol 1978; 3: 565–566.

    Article  Google Scholar 

  59. Cornblath DR. Electrophysiology in Guillain-Barré Syndrome.Ann Neurol 1990; 27 (suppl): S17-S20.

    Article  PubMed  Google Scholar 

  60. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM. Guillain-Barré Syndrome in northern China. Relationship toCampylobacter jejuni infection and anti-glycolipid antibodies.Brain 1995; 118: 597–605.

    Article  PubMed  Google Scholar 

  61. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré Syndrome.Brain 1996; 119: 2053–2061.

    Article  Google Scholar 

  62. Meulstee J, van der Meche, and the Dutch Guillain-Barré Study Group. Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barré Syndrome.J Neurol Neurosurg Psychiat 1995; 59: 482–486.

    PubMed  CAS  Google Scholar 

  63. Cornblath DR, Hughes RAC. Guillain-Barré Syndrome: the evolution of therapy.J Neurol 1994; 241: 404.

    Article  PubMed  CAS  Google Scholar 

  64. Guillain-Barré Study Group. Plasmapheresis and acute Guillain-Barré Syndrome.Neurology 1985; 35: 1096.

    Google Scholar 

  65. French Cooperative Group on plasma exchange in Guillain-Barré Syndrome. Efficiency of plasma exchange in Guillain-Barré Syndrome: role of replacement fluids.Ann Neurol 1987; 22: 753–761.

    Article  Google Scholar 

  66. Osterman PO, Lundemo G, Pirskamen R, Fagius J, Pihlsted Pet al. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy.Lancet 1984; 2: 1296–1312.

    Article  PubMed  CAS  Google Scholar 

  67. McKhann GM, Griffin JW, Cornblath DRet al. Plasmapheresis and Guillain-Barré Syndrome: analysis of prognostic factors and the effect of plasmapheresis.Ann Neurol 1988; 23: 347–353.

    Article  PubMed  CAS  Google Scholar 

  68. Van der Meche FGA, Schmitz PIM. Dutch Guillain-Barré Syndrome study group: a randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré Syndrome.N Engl J Med 1992; 326: 1123–1129.

    Article  PubMed  Google Scholar 

  69. Van der Meche FGA, van Doorn PA. Guillain-Barré Syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapy.Ann Neurol 1995; 37 (Suppl): S14.

    Article  Google Scholar 

  70. Suri M, Suri ML, Shahani BT. Intravenous gammaglobulin (IVGG) therapy in children with severe acute inflammatory demyelinating polyneuropathy (AIDP).Neurology 1993; 43: A347.

    Google Scholar 

  71. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré Syndrome.Lancet 1997; 349: 225–230.

    Article  Google Scholar 

  72. Bril V, Ilse WK, Pearce R, Dhanani A, Sutton D, Kong K. Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barré Syndrome.Neurology 1996; 46: 100–103.

    PubMed  CAS  Google Scholar 

  73. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV. Electrophysiological classification of Guillain-Barré Syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.Ann Neurol 1998; 44: 780–788.

    Article  PubMed  CAS  Google Scholar 

  74. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia ataxia and areflexia).N Engl J Med 1956; 255: 57–65.

    Article  PubMed  CAS  Google Scholar 

  75. Guiloff RJ. Peripheral nerve conduction in Miller Fisher Syndrome.J Neurol Neurosurg Psychiat 1977; 40: 801–807.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Neurology and Pediatrics, University of Mississippi School of Medicine, Jackson, MS, USA

    V. Venkataraman Vedanaryanan

  2. Department of Neurology, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Meyer 6-119, 21287, Baltimore, MD, USA

    Vinay Chaudhry

Authors
  1. V. Venkataraman Vedanaryanan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vinay Chaudhry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vinay Chaudhry.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vedanaryanan, V.V., Chaudhry, V. Guillian Barré Syndrome — Recent advances. Indian J Pediatr 67, 635–646 (2000). https://doi.org/10.1007/BF02762173

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02762173

Keywords

Search

Navigation